NYSE:NNVC
NanoViricides, Inc Stock News
$1.10
-0.0750 (-6.38%)
At Close: Apr 19, 2024
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering; 1.4M Shares At $7.30 Per Share
12:31pm, Thursday, 21'st May 2020NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering
12:30pm, Thursday, 21'st May 2020
SHELTON, CT / ACCESSWIRE / May 21, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines p
Clinical Research and Development Efforts Booming in Midst of COVID-19 Health Crisis
01:51pm, Wednesday, 20'th May 2020Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
10:15am, Wednesday, 20'th May 2020
SHELTON, CT / ACCESSWIRE / May 20, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
Honorable Ex-Congressman Todd Rokita Joins the Board of Directors of NanoViricides, Inc.
10:15am, Monday, 18'th May 2020
SHELTON, CT / ACCESSWIRE / May 18, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, announced today that Honorable M
Company News for May 13, 2020
02:12pm, Wednesday, 13'th May 2020
Companies In The News Are: GMDA, NNVC, CHAP, YRCW
NanoViricides: New Covid-19 Drug Candidates Could Boost Performance
04:57pm, Tuesday, 12'th May 2020
The research-focused biopharma player has made progress in developing and testing Continue reading...
